Zhi‐Liang Chu

2.5k citations
20 papers · 2.2k indexed · 1 hit paper · h-index 14

Zhi‐Liang Chu

19 papers receiving 2.1k citations

Hit Papers

Suppression of tumor necrosis factor-induced cell death b...19972026200620161997250500750

Peers

Zhi‐Liang Chu
Comparison fields: 5 of 98
  • Molecular Biology 1.3k
  • Endocrinology, Diabetes and Metabolism 633
  • Immunology 558
  • Cancer Research 515
  • Surgery 472
Replace Gina Lee with:
Gina Lee United States
Abderrahim Mahfoudi France
Katrin Düvel United States
Rachael Easton United States
Elizabeth M. Viney Australia
Kyungmoo Yea South Korea
Penny E. Lovat United Kingdom
Eric D. Werner United States
Jeff L. Ellsworth United States
Zhi‐Liang Chu relative to Gina Lee United States Gina Lee's profile →
Citations per field
00.5×3.9×
Gina Lee · 1×
Citations per year

Countries citing papers authored by Zhi‐Liang Chu

Since Specialization
Citations

This map shows the geographic impact of Zhi‐Liang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Liang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Liang Chu more than expected).

Fields of papers citing papers by Zhi‐Liang Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi‐Liang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Liang Chu. The network helps show where Zhi‐Liang Chu may publish in the future.

Co-authorship network of co-authors of Zhi‐Liang Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi‐Liang Chu. A scholar is included among the top collaborators of Zhi‐Liang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi‐Liang Chu. Zhi‐Liang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 14
4 3
5 2
6 1
7 24
8 53
9 39
10 10
11 103
12 321
13 117
14 248
15 152
16 112
17 44
18 46
19
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB controlbreakdown →
778
20 78

About Zhi‐Liang Chu

Zhi‐Liang Chu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Immunology, having authored 20 papers that have together received 2.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (6 papers), Immune Response and Inflammation (4 papers) and Receptor Mechanisms and Signaling (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (633 citations), Cancer Research (515 citations) and Immunology (558 citations). Zhi‐Liang Chu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Dean W. Ballard, Timothy A. McKinsey, Lily Liu, Michael H. Malim, James Leonard, Robert M. Jones, Christopher J. Carroll, Hongmei He, Dominic P. Behan and Verónica Gutiérrez. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026